Results 101 to 110 of about 13,710,280 (250)
Fairness and Improvements of the Security Mechanism for Rare Diseases Drugs
Yixue yu zhexueEnsuring access to essential rare disease treatments necessary for survival and basic health, even when costs are high, does not violate ethical or legal principles of fairness. The veil of ignorance theory can support the fairness of high-cost insurance.
Yunpeng PENG
doaj +1 more source
Free health insurance for COFA citizens. Chuukese
, 2017 Title from PDF caption (viewed on December 21, 2021)."440-5388ch."Covers OCLC #1289638689 and OCLC #1015682831."Ewe Compact of Free Association (COFA) Premium Assistance Program a awora "health insurance" weiweita ika insurance ren pekin safei/pioing ...
core
British Journal of Clinical Pharmacology, EarlyView.Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer +4 more
wiley +1 more source
Correlation of Health Insurance Provider to Orthopedic Patient Reported Outcome Measures
Foot & Ankle Orthopaedics, 2019 Category: Insurance, Outcomes Introduction/Purpose: Previous research has suggested that patient insurance type can influence health-related measures, including patient survival, quality of care, clinical outcomes after certain injuries, and likelihood ...
Jeremy T. Smith MD +1 more
doaj +1 more source
Other title: Kansas Insurance Department news release
, 2014 This internet resource contains news releases issued throughout the yearInsurance Commissioner Sandy Praeger warns consumers about proposed legislation -- Insurance Department will allow companies to extend current policies under new HHS rules ...
Kansas. Insurance Department.
core
British Journal of Clinical Pharmacology, EarlyView.Aims The glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) semaglutide and liraglutide are approved for chronic weight management. Both drugs also have favourable effects on the risk of developing diabetes and cardiovascular disease (CVD) compared with placebo, but their comparative effectiveness for these outcomes is unclear.
Ethan J. Cannon +7 more
wiley +1 more source
Capacity building in medicines development and regulation in Africa—Overview on recent progress
British Journal of Clinical Pharmacology, EarlyView.Aims Despite advances in health research and digital innovation, many African countries continue to face substantial resource constraints, fragmented capacity‐building efforts and a shortage of skilled professionals in medicines development and regulatory science.
Tirhani Maluleke +7 more
wiley +1 more source
BMC Public HealthBackground Surveillance of diagnosed mental health conditions is essential for understanding geographic disparities in healthcare access and guiding public health policy.
Wanmeng Liu +4 more
doaj +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Almost 5% of pregnancies are affected by immune‐mediated inflammatory diseases (IMIDs). As treatments become available, understanding their use during pregnancy is important. We aimed to describe maternal, pregnancy and infant outcomes among IMID pregnancies exposed to biologic therapies. Methods Using the Merative™ MarketScan® Commercial Database,
Leah K. Flatman +3 more
wiley +1 more source
, 2013 application/pdf; Annual cumulation of 2013 issuesKansas African-American college studentscan apply for insurance settlement scholarships -- Commissioner Praeger names newconsumer assistance director -- African-American college students can applyfor ...
Kansas. Insurance Department.
core